Wednesday, 24 July 2013

Upcoming PharmaCRADLE Series speakers (27th July and 16th August,2013)

27/7/13:   Mr. Jaimin Vasa, MD, Vasa Pharmachemicals Ltd.
      President, Gujarat Chemical Association since 1999
      Chairman of the MSME Committee of the Gujarat Chamber of Commerce and Industry since 2000
      Vice Chairman of Gujarat Innovation Society (GIS) since 2011
      President of Gujarat Pharmaceutical Association
      Member of Governing Council of Ahmedabad Management Association
Recognition/Award received by Vasa Pharmachem:-
2007-“Outstanding Export Performance Award” by Industries Department, Government of Gujarat 
2010 - “Growth in Production and Profit Award” in MSME Category by Government of Gujarat by Mr. Narendrabhai   Modi, Hon. Chief Minister, Government of Gujarat  for the year 2009-2010
2011 – “Best Micro Enterprise in the Pharmaceutical sector in India” for the year 2011 by D&B,  Axis Bank in the category of  Business Gaurav SME Award 2011
2012 – “INDIA SME 100 AWARD” by The Bank of India  & supported by the Union Ministry of the Small and Medium Enterprises for the year 2012

16/8/13:   Dr. Milan Satia, MD, EthiCare
Ph.D. in Pharmacology with more than 22 years of experience. Wide knowledge base and experience of
varied  facets  of  pharmaceutical  research  including  Pharmacology,  Toxicology,  Bioavailability  &
Bioequivalence Studies, Clinical Trials, Medical Writing and exposure to international Audits.  Also
conversant with Regulatory guidelines and IPR in Pharmaceutical R&D as well as CRO set up.
      Carried out more than 350 Bioavailability and Bioequivalence studies in a capacity of either as a Principal Investigator or as a scientific head.
      Co-ordinated for around 175 bioequivalence studies with various CROs in India as well as abroad as one of the assignment which resulted in submission of 86 dossiers including US, France, Brazil, South Africa etc. in a short span of 18 months.
      Actively participated in carrying out total of 50 end to end clinical trials including Phase I, Phase-II (part of NDA submission to US FDA), Phase-III and Phase IV clinical trials at different centers across India.
      A member of Board of studies at faculty of Pharmacy, Ganpat vidhyanagar, Ganpat University.
      A member of Advisory committee for B.S.Patel Pharmacy College & Sarvagenic Pharmacy College, Mehsana and Nirma Institute of Pharmacy, Ahmedabad.

1 comment: